DrugInfoSys

Melitracen (HCl)

Drug #1322

Melitracen (HCl) is a tricyclic antidepressant with actions and effects similar to amitriptyline.Melitracen (HCl) is given orally in the treatment of depression. It should be withdrawn gradually to reduce the risk of withdrawl symptoms.

Primary Characteristics

It is of Synthetic origin.

Molecular Weight: 327.9 · Non-proprietary name: Melitracen (HCl).

Molecular structure of Melitracen (HCl)

Pharmacokinetics

None recorded.

Advertisement

Indications

Melitracen (HCl) is primarily indicated in conditions like Anxiety, Asthenia, Depression, gastro-intestinal disorders associated with anxiety and agitation.

Contraindications

Melitracen (HCl) is contraindicated in conditions like Bone marrow depression, Cardiovascular disease, Cardiac disease, Pregnancy, Comatose states.

Dosage

Melitracen (HCl)'s dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
25 mg25 mgEvery 8hPOGradually increased to 225 mg if necessary. Frequency may be increased upto 3 times/day if needed.
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

None recorded.

Side Effects

Melitracen (HCl) is known to cause more or less tolerable side effects which are usually transient. These include Blurred vision, Constipation , Drowsiness, Dry mouth, Headache, Nausea, Weight gain.

Warnings / Precautions

Should be taken with precaution in Parkinsonism, renal, hepatic or CV disease, pregnancy, lactation, elderly, debilitated, respiratory disorders, diabetes, phaeochromocytoma, epilepsy, glaucoma, urinary retention, prostatic hypertrophy.

Available Brands

Click on a strength to view available brands.

Multi-Ingredient Combinations

Tabs

Storage Conditions

Melitracen (HCl) should be stored .

Drug Classification

  1. 1.24.2.1Drugs used in depression

Manufacturers

Manufacturers of Melitracen (HCl) in Pakistan: